Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Intangibles (2016 - 2025)

Nutex Health's Intangibles history spans 10 years, with the latest figure at $15.2 million for Q1 2025.

  • For Q1 2025, Intangibles changed N/A year-over-year to $15.2 million; the TTM value through Mar 2025 reached $15.2 million, changed N/A, while the annual FY2024 figure was $15.5 million, 33.24% down from the prior year.
  • Intangibles for Q1 2025 was $15.2 million at Nutex Health, down from $15.5 million in the prior quarter.
  • Across five years, Intangibles topped out at $23.3 million in Q4 2023 and bottomed at $682649.0 in Q4 2021.
  • The 5-year median for Intangibles is $15.2 million (2025), against an average of $13.9 million.
  • The largest YoY upside for Intangibles was 3174.11% in 2022 against a maximum downside of 33.44% in 2022.
  • A 5-year view of Intangibles shows it stood at $682649.0 in 2021, then skyrocketed by 3174.11% to $22.4 million in 2022, then rose by 4.08% to $23.3 million in 2023, then crashed by 33.24% to $15.5 million in 2024, then decreased by 2.09% to $15.2 million in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Intangibles are $15.2 million (Q1 2025), $15.5 million (Q4 2024), and $23.3 million (Q4 2023).